Vaccine Therapy in Treating Patients With Metastatic Melanoma Read more about Vaccine Therapy in Treating Patients With Metastatic Melanoma
A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy Read more about A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia Read more about SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer Read more about Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer
Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer Read more about Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer Read more about Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy Read more about Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU) Read more about Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks Read more about A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
MarginProbe® System U.S. Post-Approval Study Read more about MarginProbe® System U.S. Post-Approval Study